We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Andrew Southerland

Andrew M. Southerland MD, MSc

Associate Professor of Neurology and Public Health Sciences, University of Virginia, Charlottesville, Virginia

Dr. Southerland is a Harrison Distinguished Teaching Professor and Associate Professor of Neurology and Public Health Sciences at the University of Virginia. He is the principal investigator for numerous acute stroke clinical trials and was a co-investigator in the Stroke Hyperglycemia Insulin Network Effort (SHINE) study. Dr. Southerland currently serves on the Leadership Committee of the American Heart Association (AHA) Stroke Council and was on the writing committee for the 2019 AHA/ASA Updated Guideline for the Early Management of Acute Ischemic Stroke. His primary research interests include treatment in acute ischemic stroke, innovative methods of prehospital stroke care, and novel applications of telestroke care.

Disclosures

Dr. Southerland acknowledges research support (SHINE Trial NIH-NINDS UO1 NS069498, Diffusion Pharmaceuticals, American Heart Association/American Stroke Association, National Science Foundation) and provides legal expert consultation in cases related to stroke and vascular neurology.